SCHEMBL4520216

SCHEMBL4520216

COc1ccc(S(=O)(=O)Nc2ccc(C(F)(F)F)cc2)c2c1C[C@@H](N)CO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
MOGAT2 Q3SYC2 4/20 0.42
ALPL P05186 2/20 0.41
PI4KB Q9UBF8 1/20 0.41
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
TRIM24 O15164 1/20 0.39
MAPT P10636 1/20 0.38
KIF11 P52732 1/20 0.38
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4512520 0.89 MAPT (0.49) MEN1KMT2AMAPK1ALPLCYP1A2
SCHEMBL4512924 0.87 MEN1 (0.47) MEN1KMT2AALOX15MAPK1MOGAT2
SCHEMBL4519898 0.87 TP53 (0.44) MEN1KMT2AALPLALDH1A1CYP1A2
SCHEMBL4523370 0.86 CA12 (0.43) MEN1KMT2AALDH1A1CYP1A2GLA
SCHEMBL4520236 0.84 MEN1 (0.44) MEN1KMT2AALOX15MAPK1MOGAT2
SCHEMBL4523963 0.83 MEN1 (0.44) MEN1KMT2AALOX15MAPK1MOGAT2
SCHEMBL4527757 0.82 HTR6 (0.45) MEN1KMT2AALDH1A1PKMMAPT
SCHEMBL4516192 0.82 TP53 (0.51) ALPLALDH1A1CYP1A2CYP3A4PKM
SCHEMBL4519388 0.82 ADRA1A (0.51) MEN1KMT2AALOX15MAPK1MOGAT2
SCHEMBL4522821 0.82 THRB (0.55) MEN1KMT2API4KBALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor HTR6, HTR1D, HTR1A MEN1 2169/4885KMT2A 2712/4885ALOX15 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.